Ultimately, the development of retinal ischemia in DR triggers the release of the Vascular Endothelial Growth Factor (VEGF), a signaling protein that potentiates this cycle, leading to progressive ischemia and resultant neovascularization, the hallmark of proliferative diabetic retinopathy (PDR). This evidence concerns the gene VEGFA and proliferative diabetic retinopathy.